These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27184293)

  • 1. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
    Dal MS; Tekgündüz E; Çakar MK; Kaya AH; Namdaroğu S; Batgi H; Bekdemir F; Uncu Ulu B; Yiğenoğlu TN; Kılınç A; İskender D; Uğur B; Koçubaba Ş; İskender G; Altuntaş F
    Transfus Apher Sci; 2016 Aug; 55(1):125-8. PubMed ID: 27184293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial contamination of hematopoietic progenitor cell products.
    Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
    Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous transplant: microbial contamination of hematopoietic stem cell products.
    Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
    Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
    Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
    Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial contamination of peripheral blood and bone marrow hematopoietic cell products and environmental contamination in a stem cell bank: a single-center report.
    Kozlowska-Skrzypczak M; Bembnista E; Kubiak A; Matuszak P; Schneider A; Komarnicki M
    Transplant Proc; 2014 Oct; 46(8):2873-6. PubMed ID: 25380939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
    Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
    Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
    Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
    Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors.
    Sivgin S; Karakus E; Keklik M; Zararsiz G; Solmaz M; Kaynar L; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2016 Jun; 54(3):410-5. PubMed ID: 27052362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation.
    Al-Ali HK; Bourgeois M; Krahl R; Edel E; Leiblein S; Poenisch W; Basara N; Lange T; Niederwieser D
    Bone Marrow Transplant; 2011 Oct; 46(10):1296-302. PubMed ID: 21132022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
    Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual roles of autologous CD8+ T cells in hematopoietic progenitor cell mobilization and engraftment.
    Russell A; Malik S; Litzow M; Gastineau D; Roy V; Zubair AC
    Transfusion; 2015 Jul; 55(7):1758-65; quiz 1757. PubMed ID: 25757596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell mobilization and collection from pediatric patients and healthy children.
    Karakukcu M; Unal E
    Transfus Apher Sci; 2015 Aug; 53(1):17-22. PubMed ID: 26116046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of microbial contamination of haematopoietic stem cells on post-transplant outcomes: A retrospective study from tertiary care centre in India.
    Garg V; Kodan P; Pushpam D; Bakhshi S; Kumar L; Sharma A; Gupta G; Gupta N
    Transfus Med; 2021 Oct; 31(5):377-382. PubMed ID: 34396610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
    Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
    Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.